Intellia Therapeutics, Inc. · NASDAQ:NTLA
Goldman Sachs Group Inc's stake in Intellia Therapeutics, Inc. fell to 2.70% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 12, 2026
Goldman Sachs Group Inc's stake in Intellia Therapeutics, Inc. fell to 2.70%, 3,157,178 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G/A).
- Stake
- 2.70%
- Shares
- 3,157,178
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 2.70% | 3,157,178 |
| GOLDMAN SACHS & CO. LLC | 2.70% | 3,157,178 |
Source
Related
- Intellia Therapeutics, Inc.
- Goldman Sachs Group Inc
- Intellia Therapeutics, Inc. shareholders
- Schedule 13G · Goldman Sachs Group Inc · Nov 12, 2025
- Form 4 · Dube Michael P · Oct 6, 2026
- Form 4 · Leonard John M · Aug 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Dulac Edward J III · Jul 24, 2026
- Form 4 · Dulac Edward J III · Jul 6, 2026